4 ms·

The point is that we currently have a vaccine that eradicates those types of cancers but we have very low numbers of people willing to take the vaccine because

The point is that we currently have a vaccine that eradicates those types of cancers but we have very low numbers of people willing to take the vaccine because of cultural hesitancy

s1artibartfast 5y ago
I would quibble with your definition of "very low", given that the number is >50% in the US. I agree we have a preventative treatment for a cancer and not everyone takes it. What conclusions do you draw from this point as it relates to this thread (or in general)? Personally, I'm surprised that uptake is so fast for a relatively new and elective treatment. Even moreso when considering that it addresses a rare disease that effects people many decades later.
- mike00632 5y ago
  Do you have a source for that? Because my understanding is that even in young people (the original CDC target for the vaccine), the vaccination rate is under 50% in the US. https://www.cdc.gov/hpv/partners/outreach-hcp/hpv-coverage.html#:~:text=In%202017%2C%20roughly%20half%20(49,to%20start%20the%20vaccine%20series https://www.cdc.gov/hpv/partners/outreach-hcp/hpv-coverage.h....
  - s1artibartfast 5y ago
    Here is a more recent link from the CDC that puts it at 75% started and 58% complete for adolescents.[1] This isn't surprising because the CDC shows adoption going up a few percent per year. This year over year increase is more or less what you would expect given we are still in the adoption phase of this new medicine.[2] Eventually this increase will stall out with some people refusing to use it, but we aren't there yet. https://www.cdc.gov/mmwr/volumes/70/wr/mm7035a1.htm https://www.cdc.gov/mmwr/volumes/70/wr/mm7035a1.htm https://www.cdc.gov/nchs/products/databriefs/db354.htm https://www.cdc.gov/nchs/products/databriefs/db354.htm
    - mike00632 5y ago
      "for adolescents" is an important qualifier. Seems like the eligible population is still way under 50%.

The point is that we currently have a vaccine that eradicates those types of cancers but we have very low numbers of people willing to take the vaccine because of cultural hesitancy

s1artibartfast 5y ago

I would quibble with your definition of "very low", given that the number is >50% in the US. I agree we have a preventative treatment for a cancer and not everyone takes it. What conclusions do you draw from this point as it relates to this thread (or in general)? Personally, I'm surprised that uptake is so fast for a relatively new and elective treatment. Even moreso when considering that it addresses a rare disease that effects people many decades later.

mike00632 5y ago
Do you have a source for that? Because my understanding is that even in young people (the original CDC target for the vaccine), the vaccination rate is under 50% in the US. https://www.cdc.gov/hpv/partners/outreach-hcp/hpv-coverage.html#:~:text=In%202017%2C%20roughly%20half%20(49,to%20start%20the%20vaccine%20series https://www.cdc.gov/hpv/partners/outreach-hcp/hpv-coverage.h....
- s1artibartfast 5y ago
  Here is a more recent link from the CDC that puts it at 75% started and 58% complete for adolescents.[1] This isn't surprising because the CDC shows adoption going up a few percent per year. This year over year increase is more or less what you would expect given we are still in the adoption phase of this new medicine.[2] Eventually this increase will stall out with some people refusing to use it, but we aren't there yet. https://www.cdc.gov/mmwr/volumes/70/wr/mm7035a1.htm https://www.cdc.gov/mmwr/volumes/70/wr/mm7035a1.htm https://www.cdc.gov/nchs/products/databriefs/db354.htm https://www.cdc.gov/nchs/products/databriefs/db354.htm
  - mike00632 5y ago
    "for adolescents" is an important qualifier. Seems like the eligible population is still way under 50%.